Latest Insider Transactions at Healthcare Services Group Inc (HCSG)
This section provides a real-time view of insider transactions for Healthcare Services Group Inc (HCSG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HEALTHCARE SERVICES GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HEALTHCARE SERVICES GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2025
|
John Christopher Shea EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,168
-11.08%
|
-
|
|
Jan 04
2025
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,319
+5.23%
|
-
|
|
Jan 04
2025
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,956
-6.36%
|
-
|
|
Jan 04
2025
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
56,961
+4.44%
|
-
|
|
Jan 04
2025
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,035
-11.72%
|
-
|
|
Jan 04
2025
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
8,808
+6.74%
|
-
|
|
Jan 04
2025
|
Patrick J Orr EVP & Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,964
-13.98%
|
-
|
|
Jan 04
2025
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,862
+6.32%
|
-
|
|
Jan 04
2025
|
Andrew Kush EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,122
-12.55%
|
-
|
|
Jan 04
2025
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,319
+6.05%
|
-
|
|
Jan 04
2025
|
Andrew M Brophy SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
674
+2.21%
|
-
|
|
Jan 03
2025
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,161
+8.12%
|
-
|
|
Jan 03
2025
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,547
+3.42%
|
-
|
|
Jan 03
2025
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,816
+7.61%
|
-
|
|
Jan 03
2025
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,259
+9.59%
|
-
|
|
Jan 03
2025
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,061
+9.19%
|
-
|
|
Jan 03
2025
|
Andrew M Brophy SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
527
-3.53%
|
-
|
|
Jan 03
2025
|
Andrew M Brophy SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
141
+0.97%
|
-
|
|
Jan 03
2025
|
Andrew M Brophy SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,378
+31.12%
|
-
|
|
Dec 31
2024
|
Theodore Wahl President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,408
+0.65%
|
$19,264
$8.81 P/Share
|
|
Dec 31
2024
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,408
+8.99%
|
$19,264
$8.81 P/Share
|
|
Dec 31
2024
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,291
+5.95%
|
$14,201
$11.62 P/Share
|
|
Dec 31
2024
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
216
+0.8%
|
$2,376
$11.62 P/Share
|
|
Dec 31
2024
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
646
+4.79%
|
$7,106
$11.62 P/Share
|
|
Sep 30
2024
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,343
+6.56%
|
$14,773
$11.17 P/Share
|
|
Sep 30
2024
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
672
+5.23%
|
$7,392
$11.17 P/Share
|
|
Sep 30
2024
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
224
+0.84%
|
$2,464
$11.17 P/Share
|
|
Jun 30
2024
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+5.8%
|
$7,090
$10.58 P/Share
|
|
Jun 30
2024
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,418
+7.39%
|
$14,180
$10.58 P/Share
|
|
Jun 30
2024
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
237
+0.89%
|
$2,370
$10.58 P/Share
|
|
May 28
2024
|
Diane S Casey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+26.77%
|
$37,280
$10.73 P/Share
|
|
May 28
2024
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+12.48%
|
$37,280
$10.73 P/Share
|
|
May 28
2024
|
Daniela Castagnino Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+26.77%
|
$37,280
$10.73 P/Share
|
|
May 28
2024
|
Dino D Ottaviano Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+25.96%
|
$37,280
$10.73 P/Share
|
|
May 28
2024
|
John J Mc Fadden Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+26.77%
|
$37,280
$10.73 P/Share
|
|
May 28
2024
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+25.66%
|
$37,280
$10.73 P/Share
|
|
May 28
2024
|
Jude Visconto Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+26.77%
|
$37,280
$10.73 P/Share
|
|
May 28
2024
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,728
+18.56%
|
$37,280
$10.73 P/Share
|
|
Mar 31
2024
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
201
+0.89%
|
$2,412
$12.48 P/Share
|
|
Mar 31
2024
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,202
+8.69%
|
$14,424
$12.48 P/Share
|
|
Mar 31
2024
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+7.83%
|
$7,212
$12.48 P/Share
|
|
Feb 28
2024
|
Andrew M Brophy SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,125
-12.69%
|
$13,500
$12.58 P/Share
|
|
Feb 24
2024
|
Andrew M Brophy SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
239
-2.62%
|
-
|
|
Feb 24
2024
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,434
-2.52%
|
-
|
|
Feb 24
2024
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,238
+5.61%
|
-
|
|
Feb 24
2024
|
Patrick J Orr EVP & Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,417
-6.06%
|
-
|
|
Feb 24
2024
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,340
+12.49%
|
-
|
|
Feb 24
2024
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,432
-4.37%
|
-
|
|
Feb 24
2024
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+9.33%
|
-
|
|
Feb 24
2024
|
Andrew Kush EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,874
-5.17%
|
-
|